Identification and management of the hypertensive patient with elevated heart rate: Statement of a European Society of Hypertension Consensus Meeting

Journal of Hypertension

Volumn 24, Issue 4, 2006, Pages 603-610

  Palatini, Paolo ^a   Benetos, Athanase ^b   Grassi, Guido ^c   Julius, Stevo ^d   Kjeldsen, Sverre E ^e   Mancia, Giuseppe ^c   Narkiewicz, Krzystof ^f   Parati, Gianfranco ^c   Pessina, Achille C ^a   Ruilope, Luis M ^g   Zanchetti, Alberto ^h  

^a UNIVERSITY OF PADOVA   (Italy)

^b Medical School of Nancy   (France)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF MICHIGAN   (United States)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f MEDICAL UNIVERSITY OF GDANSK   (Poland)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; ETHNIC GROUP; GENDER; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SUDDEN DEATH; SYSTOLIC HYPERTENSION;

EID: 33645526700     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000217838.49842.1e     Document Type: Review

References (83)

1. Levy RL, White PD, Stroud WD, Hillman CC. Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 1945; 129:585-588.
2. Medalie JH, Kahn HA, Neufeld HN, Riss E, Goldbourt U. Five-year myocardial infarction incidence - II. Association of single variables to age and birthplace. J Chronic Dis 1973; 26:329-349.
3. Schroll M, Hagerup LM. Risk factors of myocardial infarction and death in men aged 50 at entry. A 10-year prospective study from the Glostrup population studies. Dan Med Bull 1977; 24:252-255.
4. Kannel WB, Wilson P, Blair SN. Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985; 109:876-885.
5. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113:1489-1494.
6. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112:736-749.
7. Gillmann MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: The Framingham study. Am Heart J 1993; 125:1148-1154.
8. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991; 121:172-177.
9. Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992; 20:333-239.
10. Sandvik L, Erikssen J, Ellestad M, Erikssen G, Thaulow E, Mundal R, et al. Heart rate increase and maximal heart rate during exercise as predictors of cardiovascular mortality: a 16-year follow-up study of 1960 healthy men. Coron Artery Dis 1995; 6:667-679.
11. Aronow WS, Ahn C, Mercando AD, Epstein S. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996; 78:1175-1176.
12. Mensink GB, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997; 18:1404-1410.
13. Goldberg RJ, Larson M, Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med 1996; 156:505-509.
14. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study 1. Circulation 1999; 99:1978-1983.
15. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159:585-592.
16. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality. Am J Epidemiol 1999; 149:853-862.
17. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999; 33:44-52.
18. Reunanen A, Karjalainen J, Ristola P, Heliovaara M, Knekt P, Aromaa A. Heart rate and mortality. J Intern Med 2000; 247:231-239.
19. Kristal-Boneh E, Silber H, Harari G, Froom P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000; 21:116-124.
20. Thomas F, Bean K, Provost JC, Guize L, Benetos A. Combined effects of pulse pressure and heart rate on cardiovascular mortality. J Hypertens 2001; 19:863-869.
21. Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L, Benetos A. Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 2001; 37:1256-1261.
22. Benetos A, Thomas F, Bean K, Albaladejo. Palatini P, Guize L. Resting heart rate in older people: a predictor of survival to age 85. J Am Geriatr Soc 2003; 51:284-285.
23. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement D, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162:2313-2321.
24. Fujiura Y, Adachi H, Tsuruta M, Jacobs DR Jr, Hirai Y, Imaizumi T. Heart rate and mortality in a Japanese general population: an 18-year follow-up study. J Clin Epidemiol 2001; 54:495-500.
25. Jouven X, Zureik M, Desnos M, Guerot C, Ducimetiere P. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 2001; 50:373-378.
26. Menotti A, Mulder I, Nissinen A, Feskens E, Giampaoli S, Tervahauta M, et al. Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations; the FINE study. Finland, Italy, Netherlands, Elderly. Eur Heart J 2001; 22:573-579.
27. Seccareccia F, Pannozzo F, Dima F, Minoprio A, Menditto A, Lo Noce C, et al. Heart rate as a predictor of mortality: the MATISS project. Am J Public Health 2001; 91:1258-1263.
28. Nilsson PM, Nilsson JA, Hedblad B, Berglund G. Sleep disturbance in association with elevated pulse rate for prediction of mortality - consequences of mental strain?. J Intern Med 2001; 250:521-529.
29. Chang M, Havlik RJ, Corti MC, Chaves PH, Fried LP, Guralnik JM. Relation of heart rate at rest and mortality in the Women's Health and Ageing Study. Am J Cardiol 2003; 92:1294-1299.
30. Perk G, Stessman J, Ginsberg G, Bursztyn M. Sex differences in the effect of heart rate on mortality in the elderly. J Am Geriatr Soc 2003; 51:1260-1264.
31. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes 2003; 111:215-222.
32. Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Yamaguchi J, Asayama K, et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens 2004; 17:1005-1010.
33. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Elliott P, et al. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 2004; 147:1024-1032.
34. Sega R, Facchetti R, Bombelli M, Casana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
35. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352:1951-1958.
36. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990; 65:547-553.
37. Disegni E, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Zion M, Boyko V, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol 1995; 48:1197-1205.
38. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41 021 patients. GUSTO-I Investigators. Circulation 1995; 91:1659-1668.
39. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate vs. depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 1996; 27:270-276.
40. Marchioli R, Avanzini F, Barzi F, Chieffo C, Di Castelnuovo A, Franzosi MG, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J 2001; 22:2085-2103.
41. Berton GS, Cordiano R, Palmieri R, Gheno G, Mormino P, Palatini P. Heart rate during myocardial infarction: relationship with one-year global mortality in men and women. Can J Cardiol 2002; 18:495-502.
42. Abildstrom SZ, Jensen BT, Agner E, Torp-Pedersen C, Nyvad O, Wachtell K, et al. Heart rate vs. heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol 2003; 14:168-173.
43. Kovar D, Cannon CP, Bentley JH, Charlesworth A, Rogers WJ. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol 2004; 27:80-86.
44. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26:967-974.
45. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001; 103:1428-1433.
46. Hallstrom AP, Stein PK, Schneider R, Hodges M, Scmidt G, Ulm K. Characteristics of heart beat intervals and prediction of death. Int J Cardiol 2005; 100:37-45.
47. Palatini P, Julius S. Review article: heart rate and the cardiovascular risk. J Hypertens 1997; 15:3-17.
48. Reed D, McGee D, Yano K. Biological and social correlates of blood pressure among Japanese men in Hawaii. Hypertension 1982; 4:406-414.
49. Cirillo M, Laurenzi M, Trevisan M, Stamler J. haematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension 1992; 20:319-326.
50. Narkiewicz K, Somers VK. Interactive effect of heart rate and muscle sympathetic nerve activity on blood pressure. Circulation 1999; 100:2514-2518.
51. Palatini P. Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med 2001; 33:213-221.
52. Erikssen J, Rodahl K. Resting heart rate in apparantly healthy middle-aged men. Eur J Appl Physiol 1979; 42:61-69.
53. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294:1165-1170.
54. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226:180-182.
55. Kaplan JR, Manuck SB, Adams MR, Weingand KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol in behaviourally predisposed monkeys fed an atherogenic diet. Circulation 1987; 76:1364-1372.
56. Albaladejo P, Carusi A, Apartian A, Lacolley P, Safar M, Benetos A. Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats. J Vasc Res 2003; 40:320-328.
57. Kaplan JR, Manuck SB, Clarkson TB. The influence of heart rate on coronary artery atherosclerosis. J Cardiovasc Pharmacol 1987; 10 (Suppl 2):S100-S102.
58. Bassiouny HS, Zarins CK, Kadowaki MH, Glagov S. Haemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994; 19:426-434.
59. Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996; 14:897-901.
60. Albaladejo P, Asmar R, Safar M, Benetos A. Association between 24-hour ambulatory heart rate and arterial stiffness. J Hum Hypertens 2000; 14:137-141.
61. Sa Cunha R, Pannier B, Benetos A, Siche JP, London GM, Mallion JM, Safar ME. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997; 15:1423-1430.
62. Benetos A, Adamopoulos C, Bureau J-M, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive and treated hypertensive subjects over a 6-year period. Circulation 2002; 105:1202-1207.
63. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104:1477-1482.
64. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 2:695-697.
65. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53:96-104.
66. Grassi G, Seravalle G, Magnoni M, Mancia G. Effects of cigarette smoking on systemic haemodynamics. Contrib Nephrol 2000; 130:21-30.
67. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between ageing, blood pressure, and sympathetic nerve activity. Hypertension 2005; 45:522-525.
68. Vogel CU, Wolpert C, Wehling M. How to measure heart rate? Eur J Clin Pharmacol 2004; 60:461-466.
69. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9:209-215.
70. Palatini P, Winnicki M, Santonastaso M, De Venuto G, Zanata G, Bertolo O, et al. Reproducibility of heart rate measured in the clinic and with 24-hour intermittent recorders. Am J Hypertens 2000; 13:92-98.
71. Packer M, Bristow MR, Cohn JN, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334:1349-1355.
72. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986; 57:43F-49F.
73. Kjekshus JK. Comments on beta-blockers: heart rate reduction, a mechanism of action. Eur Heart J 1985; 6 (Suppl):29.
74. The Goteborg Metoprolol Trial in acute myocardial infarction. Am J Cardiol 1984; 53:10D-50D.
75. The International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med 1984; 310:9-15.
76. Taylor SH, Silke B, Ebbutt A, Sutton G, Pout GJ, Burley DM. A long-term prevention study with oxprenolol in coronary heart disease. N Engl J Med 1982; 307:1293-1301.
77. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993; 270:1589-1595.
78. Nul DR, Doval HC, Grancelli HO, Varini SD, Soifer S, Perrone SV, et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol 1997; 29:1199-1205.
79. The Multicentre Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988; 319:385-392.
80. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction: the Danish Verapamil Infarction Trial II (DAVIT-II). Am J Cardiol 1990; 66:779-785.
81. Messerli FH, Hansen JF, Gibson RS, Schechtman KB, Boden WE. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients. J Hypertens 2001; 19:977-982.
82. Conroy RM, Piorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of 10-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
83. Di Francesco D, Camm JA. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004; 64:1757-1765.